Stocks / NASDAQ / Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc.

Our Opinion

Processa Pharmaceuticals Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that they use animals for product testing.

“The combination of PC6422 and capecitabine was also tested in several xenograft animal models with human breast, pancreatic, and colorectal cancer cells to evaluate their antitumor efficacy.” Read the following article

Company Description

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosis lipoidica, a chronic disfiguring condition. The company was incorporated in 2011 and is based in Hanover, Maryland.

Company Website: